Rexacin

Rexacin may be available in the countries listed below.

Ingredient matches for Rexacin

Norfloxacin

Norfloxacin is reported as an ingredient of Rexacin in the following countries:

• Myanmar


• Thailand

International Drug Name Search

Ranitidina Ecar

Ranitidina Ecar may be available in the countries listed below.

Ingredient matches for Ranitidina Ecar

Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ranitidina Ecar in the following countries:

• Colombia

International Drug Name Search

Apresoline

In some countries, this medicine may only be approved for veterinary use.

In the US, Apresoline (hydralazine systemic) is a member of the drug class vasodilators and is used to treat Heart Failure, High Blood Pressure and Hypertensive Emergency.

US matches:

• Apresoline

UK matches:

• Apresoline Ampoules 20 mg (SPC)
• Apresoline Tablets 25 mg (SPC)

Ingredient matches for Apresoline

Hydralazine

Hydralazine hydrochloride (a derivative of Hydralazine) is reported as an ingredient of Apresoline in the following countries:

• Australia


• Bahrain


• Canada


• Ghana


• Guyana


• Ireland


• Japan


• Kenya


• New Zealand


• Nigeria


• Oman


• Philippines


• Sudan


• Taiwan


• Tanzania


• Thailand


• United Kingdom


• Zimbabwe

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sinty

Sinty may be available in the countries listed below.

Ingredient matches for Sinty

Simvastatin

Simvastatin is reported as an ingredient of Sinty in the following countries:

• Taiwan

International Drug Name Search

Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine

Pronunciation: dif-THEER-ee-ah/TET-a-nus/aye-SELL-yoo-ler per-TUS-is/POE-lee-oh/hem-OFF-fil-us
Generic Name: Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine
Brand Name: Pentacel

Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine is used for:

Preventing diphtheria, tetanus, pertussis, polio, and haemophilus B infections in infants and children.

Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine is a vaccine for diphtheria, tetanus, pertussis, polio, and haemophilus B. It works by helping the immune system to protect against these infections.

Do NOT use Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine if:

• the patient is allergic to any ingredient in Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine


• the patient has had a severe allergic reaction (eg, severe rash, hives, difficulty breathing, dizziness) to any previous dose of this vaccine or a similar vaccine


• the patient has had brain or nervous system problems (eg, coma, prolonged seizures, unusual or severe drowsiness) from an unknown cause within 7 days after a previous pertussis-containing vaccine


• the patient has certain uncontrolled brain or nervous system problems (eg, infantile spasms, uncontrolled seizures)

Contact your doctor or health care provider right away if any of these apply the patient.

Before using Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine:

Some medical conditions may interact with Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine. Tell your doctor or pharmacist if the patient has any medical conditions, especially if any of the following applies:

• if the patient is pregnant, planning to become pregnant, or is breast-feeding


• if the patient is taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if the patient has allergies to medicines, foods, or other substances, especially latex


• if the patient has developed any of the following within 48 hours after a previous pertussis-containing vaccine: coma, high fever (greater than 105 degrees F [40.5 degrees C]) from an unknown cause, or persistent crying (for more than 3 hours)


• if the patient has a history of seizures (with or without fever) within 3 days of a previous pertussis-containing vaccine


• if the patient is very ill, weakened, or dehydrated; has a fever, infection, or other current illness; has cancer; or receives chemotherapy or radiation therapy


• if the patient has a weakened immune system (eg, HIV infection, AIDS) or takes medicine that may weaken the immune system such as immunosuppressants (eg, cyclosporine) or corticosteroids (eg, prednisone)


• if the patient has a history of nervous system problems (eg, infantile spasms, multiple sclerosis, seizures), Guillain-Barre syndrome, poor health, severe kidney problems (eg, kidney failure), or bleeding problems (eg, hemophilia, low platelets)

Some MEDICINES MAY INTERACT with Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine. Tell your health care provider if the patient is taking any other medicines, especially any of the following:

• Medicines that may weaken the immune system, immunosuppressants (eg, cyclosporine), corticosteroids (eg, prednisone), or medicines to treat cancer because they may decrease Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine may interact with other medicines that the patient takes. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine:

Use Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine is given as an injection at the patients doctor's office, hospital, or clinic.


• It is very important to receive each vaccine as scheduled. Be sure to make a note of when each vaccine was given for the child's medical record.


• If the patient misses a dose of Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine, contact the patient's doctor right away.

Ask your health care provider any questions you may have about how to use Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine.

Important safety information:

• Tell the patient's doctor or dentist that the patient has received Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine before they receive any medical or dental care, emergency care, or surgery.


• Tell the patient's doctor if the patient will be receiving other vaccines.


• Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine may not protect everyone who receives it from diphtheria, tetanus, pertussis, polio, or haemophilus B. Discuss any questions or concerns with the patient's doctor.


• Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine should not be used in INFANTS younger than 6 weeks of age or in CHILDREN who are 5 years of age or older; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine is not approved for use in adults. It is not known if Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine can cause harm to the fetus. If you use Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine and become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine while you are pregnant. It is not known if Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine is found in breast milk. If you are or will be breast-feeding and use Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine:

All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; headache; mild fever or chills; minor joint pain or swelling; minor muscle ache or weakness; minor pain, swelling, or redness at the injection site; nausea; tiredness; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blistering or sores at the injection site; bluish discoloration of the fingers; fainting; muscle spasms; numbness or tingling of the arms or legs; paleness; seizure; severe or persistent fever, chills, dizziness, diarrhea, or vomiting; severe or persistent irritability (eg, unusual crying, screaming, restlessness); severe or persistent joint pain or swelling; shortness of breath; signs of dehydration (eg, decreased amount of urine, very dry lips or mouth); unresponsiveness.

This is not a complete list of all side effects that may occur. If you have questions or need medical advice about side effects, contact your doctor or health care provider. You may report side effects to FDA at 1-800-FDA-1088 or at http://www.fda.gov/medwatch.

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine:

Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine is usually handled and stored by a health care provider. If you are using Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine at home, store Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine as directed by your pharmacist or health care provider. Protect from light. Keep Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine out of the reach of children and away from pets.

General information:

• If you have any questions about Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine, please talk with your doctor, pharmacist, or other health care provider.


• Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine resources

• Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine Use in Pregnancy & Breastfeeding
• Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine Drug Interactions
• Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine Support Group
• 0 Reviews for Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate - Add your own review/rating

Compare Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis, Inactivated Polio, and Haemophilus B Conjugate Vaccine with other medications

• Diphtheria Prophylaxis
• Haemophilus influenzae Prophylaxis
• Pertussis Prophylaxis
• Poliomyelitis Prophylaxis
• Tetanus Prophylaxis

Evoxac

Evoxac is a brand name of cevimeline, approved by the FDA in the following formulation(s):

EVOXAC (cevimeline hydrochloride - capsule; oral)

• 
  Manufacturer: DAIICHI SANKYO CO
  
  Approval date: January 11, 2000
  
  Strength(s): 30MG ^[RLD][AB]

Has a generic version of Evoxac been approved?

A generic version of Evoxac has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Evoxac and have been approved by the FDA:

CEVIMELINE (cevimeline hydrochloride capsule; oral)

• 
  Manufacturer: APOTEX INC
  
  Approval date: August 25, 2011
  
  Strength(s): 30MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Evoxac. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Composition and method for treating Sjoegren syndrome disease
  Patent 5,340,821
  Issued: August 23, 1994
  Inventor(s): Abe; Nobuaki & Takeshita; Yasuyoshi
  Assignee(s): Snow Brand Milk Products Co., Ltd.
  A composition for treating a Sjoegren syndrome disease is disclosed. The composition comprising derivative of spirooxathiolane-quinuclidine of the following formula (I), ##STR1## wherein Z is .dbd.CR.sup.1 R.sup.2, wherein R.sup.1 and R.sup.2 may be the same or different and each represents hydrogen, alkyl, cyclopentyl, cyclohexyl, aryl, diarylmethylol, or alkyl which may be substituted by one or more aryl groups, or an acid addition salt thereof, or an acid addition salt thereof, as an effective component. Especially effective is an administration of a hydrochloric acid addition salt of 2-methylspiro(1,3-oxathiolane-5,3')quinuclidine.
  
  Patent expiration dates:
  
  
  • July 7, 2013
    
    ✓ 
    Patent use: TREATING SJOEGREN SYNDROME
  
  

See also...

• Evoxac Consumer Information (Wolters Kluwer)
• Evoxac Consumer Information (Cerner Multum)
• Evoxac Advanced Consumer Information (Micromedex)
• Evoxac AHFS DI Monographs (ASHP)
• Cevimeline Consumer Information (Wolters Kluwer)
• Cevimeline Consumer Information (Cerner Multum)
• Cevimeline Advanced Consumer Information (Micromedex)
• Cevimeline Hydrochloride AHFS DI Monographs (ASHP)

TMP Sulfa Noé

TMP Sulfa Noé may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for TMP Sulfa Noé

Sulfadiazine

Sulfadiazine is reported as an ingredient of TMP Sulfa Noé in the following countries:

• France

Trimethoprim

Trimethoprim is reported as an ingredient of TMP Sulfa Noé in the following countries:

• France

International Drug Name Search

Carbachol

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N07AB01,S01EB02

CAS registry number (Chemical Abstracts Service)

0000051-83-2

Chemical Formula

C6-H15-Cl-N2-O2

Molecular Weight

182

Therapeutic Categories

Parasympathomimetic agent, direct acting

Miotic agent

Chemical Name

Ethanaminium, 2-[(aminocarbonyl)oxy]-N,N,N-trimethyl-, chloride

Foreign Names

• Carbacholum (Latin)
• Carbachol (German)
• Carbachol (French)
• Carbacol (Spanish)

Generic Names

• Carbachol (OS: BAN, DCF)
• Carbacolo (OS: DCIT)
• Carbamylcholine chloride (IS)
• Choline chloride carbamate (IS)
• Cholinergol (IS)
• Karbaminoylcholinchlorid (IS: ÖAB)
• Samoryl (IS)
• Carbachol (PH: BP 2010, USP 32, Ph. Eur. 6)
• Carbacholum (PH: Ph. Int. 2, Ph. Eur. 6)
• Carbacolo (PH: Ph. Eur. 6)

Brand Names

• Biolent (veterinary use)
  Drwalewskie Zaklady Przemyslu Bioweterynaryjnego, Poland



• Carbastat
  Novartis Ophthalmics, United States



• Carboptic
  NutraMax, United States



• Isopto Carbachol
  Alcon, Australia; Alcon, Botswana; Alcon, Canada; Alcon, Germany; Alcon, Eritrea; Alcon, Ghana; Alcon, Israel; Alcon, Kenya; Alcon, Luxembourg; Alcon, Malawi; Alcon, Namibia; Alcon, Nigeria; Alcon, Tanzania; Alcon, Uganda; Alcon, United States; Alcon, Zambia; Alcon, Zimbabwe



• Isopto Carbachol (veterinary use)
  Alcon, United Kingdom



• Isopto-Karbakolin
  Alcon, Sweden



• Miostat
  Alcon, Australia; Alcon, Canada; Alcon, Switzerland; Alcon, Czech Republic; Alcon, France; Alcon, Georgia; Alcon, Hungary; Alcon, Israel; Alcon, Luxembourg; Alcon, Netherlands; Alcon, Poland; Alcon, Romania; Alcon, Sweden; Alcon, Singapore; Alcon, Slovenia; Alcon, Turkey; Alcon, Taiwan; Alcon, United States; Alcon-Couvreur, Belgium



• Mioticol
  Farmigea, Italy

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Doxivit

Doxivit may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Doxivit

Doxycycline

Doxycycline hyclate (a derivative of Doxycycline) is reported as an ingredient of Doxivit in the following countries:

• Switzerland

International Drug Name Search

Reutren

Reutren may be available in the countries listed below.

Ingredient matches for Reutren

Diclofenac

Diclofenac diethylamine (a derivative of Diclofenac) is reported as an ingredient of Reutren in the following countries:

• Bangladesh

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Reutren in the following countries:

• Bangladesh

International Drug Name Search